Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lindhout

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Thrombosis and Haemostasis|February 28, 1989
The mode of action of low molecular weight heparin preparation (PK10169) and two of its major components on thrombin generation in plasmaS Béguin, J Mardiguian, T Lindhout, et al.
The Biochemical Journal|January 1, 1994
Kinetics of the inhibition of human factor Xa by full-length and truncated recombinant tissue factor pathway inhibitorT Lindhout, G Willems, R Blezer, et al.
Thrombosis and Haemostasis|December 1, 1995
Inhibition of factor X activation at extracellular matrix of fibroblasts during flow conditions: a comparison between tissue factor pathway inhibitor and inactive factor VIIaS Valentin, C P Reutlingsperger, O Nordfang, et al.
Thrombosis and Haemostasis|August 4, 1987
Thrombin-induced platelet factor Va formation in patients with a gray platelet syndromeD Baruch, T Lindhout, E Dupuy, et al.
Annals of the New York Academy of Sciences|January 1, 1989
The ex vivo correlate of the antithrombotic action of heparinH C Hemker, S Béguin, J Pieters, et al.
Thrombosis and Haemostasis|October 1, 1991
Low molecular weight heparin-catalyzed inactivation of factor Xa and thrombin by antithrombin III--effect of platelet factor 4P Schoen, T Lindhout, J Franssen, et al.
Journal of Biomedical Materials Research|October 23, 1997
Activation of blood coagulation at heparin-coated surfacesR Blezer, B Fouache, G M Willems, et al.
Thrombosis Research|June 1, 1985
Effect of heparin and low molecular weight heparins on thrombin-induced blood platelet activation in the absence of antithrombin IIID Baruch, J Franssen, H C Hemker, et al.
Thrombosis and Haemostasis|December 28, 1990
Continuous flow and the prothrombinase-catalyzed activation of prothrombinP Schoen, T Lindhout, G Willems, et al.
Haemostasis|October 1, 1996
Tissue factor pathway inhibitor: regulation of its inhibitory activity by phospholipid surfacesT Lindhout, I Salemink, S Valentin, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Thrombosis and Haemostasis|February 28, 1989
The mode of action of low molecular weight heparin preparation (PK10169) and two of its major components on thrombin generation in plasmaS Béguin, J Mardiguian, T Lindhout, et al.
The Biochemical Journal|January 1, 1994
Kinetics of the inhibition of human factor Xa by full-length and truncated recombinant tissue factor pathway inhibitorT Lindhout, G Willems, R Blezer, et al.
Thrombosis and Haemostasis|December 1, 1995
Inhibition of factor X activation at extracellular matrix of fibroblasts during flow conditions: a comparison between tissue factor pathway inhibitor and inactive factor VIIaS Valentin, C P Reutlingsperger, O Nordfang, et al.
Thrombosis and Haemostasis|August 4, 1987
Thrombin-induced platelet factor Va formation in patients with a gray platelet syndromeD Baruch, T Lindhout, E Dupuy, et al.
Annals of the New York Academy of Sciences|January 1, 1989
The ex vivo correlate of the antithrombotic action of heparinH C Hemker, S Béguin, J Pieters, et al.
Thrombosis and Haemostasis|October 1, 1991
Low molecular weight heparin-catalyzed inactivation of factor Xa and thrombin by antithrombin III--effect of platelet factor 4P Schoen, T Lindhout, J Franssen, et al.
Journal of Biomedical Materials Research|October 23, 1997
Activation of blood coagulation at heparin-coated surfacesR Blezer, B Fouache, G M Willems, et al.
Thrombosis Research|June 1, 1985
Effect of heparin and low molecular weight heparins on thrombin-induced blood platelet activation in the absence of antithrombin IIID Baruch, J Franssen, H C Hemker, et al.
Thrombosis and Haemostasis|December 28, 1990
Continuous flow and the prothrombinase-catalyzed activation of prothrombinP Schoen, T Lindhout, G Willems, et al.
Haemostasis|October 1, 1996
Tissue factor pathway inhibitor: regulation of its inhibitory activity by phospholipid surfacesT Lindhout, I Salemink, S Valentin, et al.
Pageof 8